期刊文献+

用缬沙坦联合利血平治疗高血压的效果 被引量:1

The Effect of Valsartan Combined With Reserpine in the Treatment of Hypertension
下载PDF
导出
摘要 目的探讨高血压患者使用缬沙坦联合利血平治疗及护理效果。方法选取2016年3月—2017年3月我院就诊的高血压患者共70例作为研究对象。采用随机数字抽签法,将其分为对照组和观察组,每组各35例。对照组给予利血平治疗,观察组在此基础上,加用缬沙坦治疗,比较治疗前后患者血压收缩压SBP和舒张压DBP水平,统计患者心脑血管疾病发生率。结果观察组患者的血压显著下降,效果优于对照组,差异具有统计学意义(P<0.05),观察组患者的心脑血管疾病发生率较对照组显著降低,差异具有统计学意义(P<0.05)。结论缬沙坦联合利血平治疗高血压的临床效果显著,可控制血压,降低其他不良事件的发生率。 Objective To explore the effect of valsartan and reserpine in the treatment and nursing of hypertensive patients.Methods 70 cases of hypertension patients in our hospital from March 2016 to March 2017 were selected and divided into the control group and the observation group by random digital drawing,35 cases in each group.The control group was treated with reserpine,and the observation group was additionally treated with valsartan.The blood pressure,systolic blood pressure(SBP)and diastolic blood pressure(DBP)level before and after treatment were compared,and the incidence of cardiovascular and cerebrovascular diseases was statistically analyzed.Results The blood pressure in the observation group was significantly lower than that in the control group,the difference was statistically significant(P<0.05),and the incidence of cardiovascular and cerebrovascular diseases in the observation group was significantly lower than that in the control group,the difference was statistically significant(P<0.05).Conclusion The clinical effect of valsartan combined with reserpine in the treatment of hypertension is significant.It can control blood pressure and reduce the incidence of other adverse events.
作者 张咏梅 ZHANG Yongmei(Public Health Department,Maojian District People's Hospital of Shiyan City,Shiyan Hubei 442000,China)
出处 《中国继续医学教育》 2018年第13期101-103,共3页 China Continuing Medical Education
关键词 缬沙坦 利血平 高血压 疗效 valsartan reserpine hypertension curative effect
  • 相关文献

参考文献10

二级参考文献61

  • 1LIU Yi,XU Yu lan,ZHEN Chen fei,WANG Lu ping Blood Detoxification Department ,the First Affiliated Hospital Wenzhou Medical College,Zhejiang province,wenzhou 325000,China.Prevalence of hypertension in a hemodialysis population[J].Chinese Journal of Biomedical Engineering(English Edition),2000,9(3):111-116. 被引量:1
  • 2唐祥囡.重视时间护理 提高护理质量[J].天津护理,2005,13(1):46-46. 被引量:19
  • 3张福康,石壬伟,康志荣,窦芒,胡强燕.终末期肾脏病血液透析患者高血压的药学监护[J].中国药师,2007,10(11):1122-1123. 被引量:5
  • 4Mancia G, De Backer G, Dominiczak A, et al. 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hy- pertension (ESH) and of the European Society of Cardiology (ESC) [J]. J Hypertens, 2007,25 (6) :1106-1187.
  • 5Gerbino PP, Shoheiber O. Adherence patterns among patients treated with fixed-does combination versus separate antihypertens- ire agents [ J]. Am J Health Syst Pharm, 2007,64 (12):1379- 1283.
  • 6刘鸣.系统评价、Meta-分析设计与设计方法[M].北京:人民卫生出版社,2011.
  • 7赵文强,王连进.缬沙坦/氨氯地平在高血压治疗中的应用[J].医药前沿,2013(3):217.
  • 8Parati G, Faini A, Valentini M. Blood pressure variation: its measurement and significance in hypertention [ J ]. Curt Hypertens Rep, 2006,8 (9) : 199-204.
  • 9赵春艳.社区高血压规范化管理49例疗效分析[J].健康必读,2012,11(6):606-607.
  • 10黄晓筠.社区老年高血压患者用药管理的护理干预[J].中国保健营养,2014,24(4):2230.

共引文献103

同被引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部